Regulatory requirements for drug approval differ by country. For a Marketing Authorization Application, satisfying each country's unique requirements is challenging. It is important to understand the regulations for approval in each market. In India specifically, companies must apply to the licensing authority and submit clinical trial data and reports according to the Drugs and Cosmetics Act of 1940 to gain approval for manufacturing or importing a new drug. Drug development teams are responsible for integrating research results, planning studies, and monitoring projects to ensure drugs are safely and effectively developed according to timelines and regulations.
Regulatory requirements for drug approval differ by country. For a Marketing Authorization Application, satisfying each country's unique requirements is challenging. It is important to understand the regulations for approval in each market. In India specifically, companies must apply to the licensing authority and submit clinical trial data and reports according to the Drugs and Cosmetics Act of 1940 to gain approval for manufacturing or importing a new drug. Drug development teams are responsible for integrating research results, planning studies, and monitoring projects to ensure drugs are safely and effectively developed according to timelines and regulations.
Regulatory requirements for drug approval differ by country. For a Marketing Authorization Application, satisfying each country's unique requirements is challenging. It is important to understand the regulations for approval in each market. In India specifically, companies must apply to the licensing authority and submit clinical trial data and reports according to the Drugs and Cosmetics Act of 1940 to gain approval for manufacturing or importing a new drug. Drug development teams are responsible for integrating research results, planning studies, and monitoring projects to ensure drugs are safely and effectively developed according to timelines and regulations.
Currently different countries have to follow different regulatory requirements for
approval of new drug. For Marketing Authorization Application (MAA) : a single regulatory approach is applicable to various countries is almost a difficult task. Therefore, it is necessary to have knowledge about regulatory requirement for MAA of each country. Each country Regulatory requirements for drug has its own regulatory requirements which have to be satisfied to approve a new drug in that particular country. approval: Drug Development Teams
Regulation of Drug Approval Process
DRUG DESCOVERY AND DEVELOPMENT
Approval of New Drug in India : If any company in India wants to manufacture or import a new drug, apply to seek permission from the licensing authority (DCGI) by filing in Form 44 also submitting the data as given in Schedule Y of Drugs and Cosmetics Act 1940 and Rules 1945.
To prove its efficacy and safety in Indian population they
need to conduct clinical trials in accordance with the guidelines specified in Schedule Y and submit the report of such clinical trials in specified format.
The regulations under Drugs and Cosmetics Act 1940 and
its rules 1945, 122A, 122B and 122D describe the information required for approval of an application to import or manufacture of new drug for marketing.
Drug Development Teams & Their Responsibilities
Some of the rules & guidelines that should be followed The drug development team includes a diverse group of individuals with different for regulation of drugs in India are: philosophies and approaches to the development process. All team members must work closely together to ensure that a drug is both safe and efficacious. Drugs and Cosmetics Act 1940 and its rules 1945 The responsibilities of these project teams include – Narcotic Drugs and Psychotropic Substances -1985 1. Reviewing research results from experiments conducted by any of the various scientific disciplines. Drugs Price Control Order 1995 2. Integrating new research results with previously generated data. 3. Planning research studies to further characterize a drug candidate. Consumer Protection Act-1986 4. Preparing a detailed drug development plan, including designation of key points or development milestones, generating a timeline for completion, and defining the Factories Act-1948 critical path. 5. Monitoring the status of research studies to ensure that they are being conducted Law of Contracts (Indian contract Act-1872) according to the timeline and critical path in the development plan and, if appropriate, modifying the plan as new information becomes available. Monopolistic & Restrictive Trade Practices Act-1969 6. Comparing research results and development status and timelines with drug candidates under development by competitors. ICH GCP Guidelines 7. Conducting appropriate market surveys to ensure that the development of a drug candidate is economically justified and continues to meet a medical need.